Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia

Clinical trial NCT00792831 · TERMINATED

Trial details

NCT number: NCT00792831
Sponsor: Italfarmaco
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2008-02-01
Primary completion: 2009-04-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.